Skip to main content

Tweets

Single center study of anti-PhosphoLipd Abs in 149 Bx proven lupus nephritis pts 36% had APL Abs (18.8% IgG, 18.1% IgM, 10.7% B2GlyP, 8.1% LAC). F/U of 156 mos - APL+ had lower 10 yr survival (91 vs 99%). lower GFR, more thrombotic events & miscarriage https://t.co/U5ra02wMmX

Dr. John Cush @RheumNow ( View Tweet )

6 years 9 months ago
SURVEY: When choosing drug therapy for GCA, what mechanism are you targeting? IL-1, IL-6, TNF, inflammation? Survey for RHEUMATOLOGISTS - please vote here>> https://t.co/qhpOxYz3Qt

Dr. John Cush @RheumNow ( View Tweet )

6 years 9 months ago
Statin induced myopathy is occurs in less than 1%; rhabdomyolysis and necrotizing myositis are very rare. HMGCR Abs against (HMG-CoA) reductase are seen 2- 3 of every 100,000 patients treated with statins. https://t.co/44DGaHEGjo

Dr. John Cush @RheumNow ( View Tweet )

6 years 9 months ago
RheumNow Survey for Rheumatologists – In Giant Cell Arteritis - When do you add a steroid sparing agent? https://t.co/qhpOxYhsYV

Dr. John Cush @RheumNow ( View Tweet )

6 years 9 months ago
RISE registry: among 7,274 RA pts w/ serial data [RAPID3 (78.9%) & CDAI (34.2%)]. Amongst those w/ moderate/high disease activity, frequency of DMARD change was low (36%-55%). Less likely to change was elderly, Combo DMARDs or biologics. https://t.co/IppHCxJWk1

Dr. John Cush @RheumNow ( View Tweet )

6 years 9 months ago
Followup of 783 tofacitinib‐treated psoriatic arthritis patients finds increases in LDL and HDL 9% to 14% after 3 and 6 months of therapy with a low risk of HTN or MACE events https://t.co/fh6UbmF3lr

Dr. John Cush @RheumNow ( View Tweet )

6 years 9 months ago
RheumNow LIVE VOTE Survey: When treating a patient for GCA, when might you add a steroid-sparing agent?? If youre a RHEUMATOLOGIST - please vote in our quick 4Q survey https://t.co/qhpOxYhsYV

Dr. John Cush @RheumNow ( View Tweet )

6 years 9 months ago
Comparison of 69 SLE pts w/ C/S+ infection vs 69 SLE without infx shows that serum procalitonin did not distinguish those w/ infection, BUT C-reactive protein did successfully identify those SLE patients with infection https://t.co/HMHqfaP0Cg

Dr. John Cush @RheumNow ( View Tweet )

6 years 9 months ago
Taiwanese Claims data study shows the risk of opportunistic infection in ~77K autoimmune pts shows OI highes in PM/DM cases (61.3/1000PY), followed by SLE (43.1/1000PY), SSc (31.6), RA (25), and pSS (24.1). OI risk highest during 1st year https://t.co/YKP7ZF7FIx

Dr. John Cush @RheumNow ( View Tweet )

6 years 9 months ago
Study of 179 RA pts achieving remission on TCZ- SC 162 mg qwk randomized to continue qWk or space out to q2Wk -- Weekly Actemra better maintained remission (90% versus 73%; P = 0.004), but then again 73% did well w/ spacing to every other week. https://t.co/ywvsDMxS6M

Dr. John Cush @RheumNow ( View Tweet )

6 years 9 months ago
Logical + Data-driven = Annoying. (If you have high standards does that make you arrogant?)

Dr. John Cush @RheumNow ( View Tweet )

6 years 10 months ago
RheumNow Podcast is up! When you're hot you're hot! Watch it on youtube>> https://t.co/GlqMzjUnhE or listen to the podcast on iTues, Apple podcast or on Stitcher or SoundCloud>> https://t.co/a1zE7VXtog

Dr. John Cush @RheumNow ( View Tweet )

6 years 10 months ago
China retrospective study of 727 SoA abd 857 RA pts shows risk of H. Zoster same between SpA & RA (aHZ=0.97), but was significantly higher with MTX (adj HR 3.47) and infliximab (adj HR 10.67) https://t.co/gpictKPpIT

Dr. John Cush @RheumNow ( View Tweet )

6 years 10 months ago

RheumNow Podcast is up! When youre hot youre hot! Watch it on youtube>> https://t.co/GlqMzjUnhE or listen to the podcast in your car on iTues, Apple podcast or on Stitcher or SoundCloud>> https://t.co/a1zE7VXtog

Dr. John Cush @RheumNow ( View Tweet )

6 years 10 months ago
How would you describe your "BEST" patient in just 3 words? https://t.co/j1CEAiUdvo

Dr. John Cush @RheumNow ( View Tweet )

6 years 10 months ago
×